Soon after our newsroom went remote for the pandemic, I learned our feature subject, Everlywell CEO Julia Cheek, was racing to build a scalable at-home Covid test, which became the first FDA-authorized standalone at-home Covid sample collection kit. Her story was the first thing I’d read that explained why nobody could get tested. We pulled the planned cover hours before it shipped, and the team rebuilt the issue around her in a day.
